✉news ScienceBiology first seen 3 d ago, last 3 d ago, peak #29
New biological marker could end trial and error in depression care
Researchers are reporting the identification of a biological marker that could help guide treatment for depression, potentially allowing doctors to match patients to the right therapy from the start instead of relying on trial and error with antidepressants. Mental health specialists have long sought objective tools to predict which medications will work for individual patients, and the announcement is drawing attention as a possible step toward more personalised depression care.
Why now: People are discussing the potential for biomarker-based testing to spare depression patients months of ineffective medication switching.
depressionbiomarkersantidepressantsmental health care
Rank over time, top of the chart is #1. 2 snapshots from 3 d ago to 3 d ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/3254889